This is a field sales role where you would be required to visit doctors, chemists & stockists. You will be responsible for achieving the tertiary and secondary business of the division in the respective territory and therapy by managing relationships with the key stakeholders viz. doctors & chemists and by creating prescriptions by marketing the company's brands and providing superior customer service thereby achieving the company's overall business targets for the division in India.
Key responsibilities:
1. Achieve the sales targets by brand marketing against the plan for the year
2. Monitor business details thereby planning the sales achievement
3. Maintain the basic working standards for daily operations
4. Develop and continuously enhance in-clinic effectiveness for driving better results and increasing prescriptions
5. Manage customer relationships for continued engagement of key support customers
Salary structure:
1. Fixed component - 2.8 LPA
2. Incentives - up to 3 LPA which you will start earning post confirmation
3. Travel allowance (actual basis) - up to 9,000 per month from the day of joining
1. Only women candidates can apply
2. Available to join latest by 31st of March 2025
3. Candidate must have a degree in - pharmacy, pharmaceutical management, biotechnology, microbiology, chemistry, biology, or zoology
4. Candidates graduating in 2025 can apply provided they are available to join latest by 31st March 2025
5. Candidates with field sales experience (in any industry) are encouraged to apply
6. Having a valid vehicle license is a plus
Annual CTC: ₹ 2,80,000 /year
Information above is Internshala's interpretation and paraphrasing of what we found on the shared link.
Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.